Abcellera Biologics Inc
Change company Symbol lookup
Select an option...
ABCL Abcellera Biologics Inc
FRME First Merchants Corp
SFDMY Shanghai Fudan Microelectronics Group Co Ltd
NWL Newell Brands Inc
MRK Merck & Co Inc
FWONA Liberty Media Corp
RSG Republic Services Inc
TENB Tenable Holdings Inc
NLSN Nielsen Holdings PLC
CLAR Clarus Corp

Health Care : Life Sciences Tools & Services | Mid Cap Blend
Based in Canada
Company profile

AbCellera Biologics Inc. (AbCellera) is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

Closing Price
Day's Change
-0.45 (-3.12%)
B/A Size
Day's High
Day's Low

10-day average volume:

Upcoming Events

ABCL's fiscal year ends in December
There are no upcoming events for ABCL

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
November 9, 2021Q3 2021 Earnings Release-$0.08-$0.08 to -$0.01--
August 12, 2021Q2 2021 Earnings Release-$0.01$0.03 to $0.15--
May 13, 2021Q1 2021 Earnings Release$0.37$0.36 to $0.413--
March 29, 2021Q4 2020 Earnings Release$0.44$0.41 to $0.81--

Past IPOs

DateEvent descriptionAmount of offeringNumber of sharesExpected price range
December 11, 2020Abcellera Biologics Inc Initial Public Offering$48,300,0002,415,000$20.00 to $20.00

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.